Sfoglia per AUTORE
BONGO AS
Collezione AOU Novara

  

Items : 38

Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs. in Journal of thoracic disease / J Thorac Dis. 2018 Feb;10(2):678-681. doi: 10.21037/jtd.2018.01.108.

2018
AOU Novara

Lupi A; Schaffer A; Bongo AS;

Can neuroimaging differentiate PFO and AF-related cardioembolic stroke from the other embolic sources? Clinical-radiological correlation on a retrospective study. in La Radiologia medica / Radiol Med. 2017 Jun;122(6):412-418. doi: 10.1007/s11547-017-0738-6. Epub 2017 Feb 21.

2017
AOU Novara

Stecco A; Quagliozzi M; Soligo E; Naldi A; Cassarà A; Coppo L; Rosso R; Bongo AS; Amatuzzo P; Buemi F; Guenzi E; Carriero A;

Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications. in American journal of cardiovascular drugs : drugs, devices, and other interventions / Am J Cardiovasc Drugs. 2016 Dec;16(6):391-397. doi: 10.1007/s40256-016-0186-z.

2016
ASL Vercelli
ASL VCO
AOU Novara

Porto I; Jaffe AS; Cortese B; Bongo AS; Cavallino C; Rognoni A; Schaffer A; Angiolillo DJ; Lupi A;

Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility. in Cardiovascular revascularization medicine : including molecular interventions / Cardiovasc Revasc Med. 2016 Dec;17(8):528-534. doi: 10.1016/j.carrev.2016.08.005. Epub 2016 Aug 20.

2016
ASL VCO
AOU Novara

De Martino L; Rognoni A; Tessitori M; Lazzero M; Schaffer A; Lupi A; Bongo AS; Porto I;

Correlations between microRNAs and their target genes in skeletal myoblasts cell therapy for myocardial infarction. in Annals of translational medicine / Ann Transl Med. 2016 Aug;4(15):292. doi: 10.21037/atm.2016.05.65.

2016
AOU Novara
ASL Vercelli

Rognoni A; Cavallino C; Rametta F; Bongo AS;

Ticagrelor: Long-Term Therapy in Patients with Coronary Artery Disease. in Reviews on recent clinical trials / Rev Recent Clin Trials. 2016;11(4):280-283. doi: 10.2174/1574887111666160729102848.

2016
AOU Novara
ASL Vercelli

Rognoni A; Cavallino C; Lupi A; Bacchini S; Rosso R; Rametta F; Nardi F; Bongo AS;

Similar anti-inflammatory effects of intracoronary and intravenous abciximab during primary percutaneous coronary intervention: a randomized study. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):189-96. doi: 10.2459/JCM.0000000000000119.

2015
AOU Novara

Secco GG; Sansa M; Rognoni A; Parisi R; Fattori R; Rossi L; Lazzero M; Rolla R; Bellomo G; Bongo AS; Agostoni P; Di Mario C; Lupi A;

Pathophysiology of Atherosclerotic Plaque Development. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2015;13(1):10-3. doi: 10.2174/1871525713666141218163425.

2015
AOU Novara
ASL Vercelli

Rognoni A; Cavallino C; Veia A; Bacchini S; Rosso R; Facchini M; Secco GG; Lupi A; Nardi F; Rametta F; Bongo AS;

Beta-Blockers and Nitrates: Pharmacotherapy and Indications. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2015;13(1):25-30. doi: 10.2174/1871525713666141219114708.

2015
AOU Novara
ASL Vercelli

Facchini E; Degiovanni A; Cavallino C; Lupi A; Rognoni A; Bongo AS;

New Anti-Anginal Drugs: Ranolazine. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2015;13(1):14-20. doi: 10.2174/1871525713666141219112841.

2015
AOU Novara
ASL Vercelli

Cavallino C; Facchini M; Veia A; Bacchni S; Rosso R; Rognoni A; Rametta F; Lupi A; Bongo AS;

Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2015;13(1):4-9. doi: 10.2174/1871525713666141218162102.

2015
AOU Novara
ASL Vercelli

Lupi A; Rognoni A; Cavallino C; Secco GG; Rosso R; Bongo AS;

Complex Coronary Interventions with the Novel Mozec™ CTO Balloon: The MOZART Registry. in Clinical Medicine Insights. Cardiology / Clin Med Insights Cardiol. 2015 Aug 27;9:91-6. doi: 10.4137/CMC.S25552. eCollection 2015.

2015
AOU Novara

Lupi A; Rognoni A; Schaffer A; Secco GG; Bongo AS;

Aortic counterpulsation in cardiogenic shock during acute myocardial infarction. in Expert review of cardiovascular therapy / Expert Rev Cardiovasc Ther. 2014 Jul;12(7):913-7. doi: 10.1586/14779072.2014.921116. Epub 2014 May 2

2014
AOU Novara
ASL Vercelli

Rognoni A; Cavallino C; Lupi A; Veia A; Rosso R; Rametta F; Bongo AS;

Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registry. in The Journal of invasive cardiology / J Invasive Cardiol. 2014 Jul;26(7):311-7.

2014
AOU Novara

Lupi A; Porto I; Rognoni A; Lazzero M; Fattori R; Parisi R; De Maria GL; Bongo AS; Sheiban I; Bolognese L; Agostoni P; Secco GG;

Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients. in European journal of preventive cardiology / Eur J Prev Cardiol. 2014 Apr;21(4):411-24. doi: 10.1177/2047487312467745. Epub 2012 Nov 14.

2014
AOU Novara

Lupi A; Rognoni A; Secco GG; Lazzero M; Nardi F; Fattori R; Bongo AS; Agostoni P; Sheiban I;

Ticagrelor: a novel drug for an old problem. in Recent patents on cardiovascular drug discovery / Recent Pat Cardiovasc Drug Discov. 2014;9(1):51-7. doi: 10.2174/1574890109666140901150224.

2014
AOU Novara

Rognoni A; Cavallino C; Lupi A; Secco GG; Veia A; Bacchini S; Rosso R; Brunelleschi S; Rametta F; Bongo AS;

Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients. in International journal of cardiology / Int J Cardiol. 2013 Oct 12;168(5):4608-16. doi: 10.1016/j.ijcard.2013.07.161. Epub 2013 Jul 26.

2013
AOU Novara

Lupi A; Rognoni A; Secco GG; Porto I; Nardi F; Lazzero M; Rossi L; Parisi R; Fattori R; Genoni G; Rosso R; Stella PR; Sheiban I; Bolognese L; Liistro F; Bongo AS; Agostoni P;

Intracoronary injection of drugs to treat no--reflow phenomenon and microcirculatory dysfunction. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):84-8. doi: 10.2174/1871525711311020002.

2013
AOU Novara

Rognoni A; Lupi A; Cavallino C; Secco GG; Rosso R; Bongo AS;

Intracoronary injection of glycoprotein IIb/IIIa, abciximab, as adjuvant therapy in primary coronary intervention. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):89-95. doi: 10.2174/1871525711311020003.

2013
AOU Novara

Rognoni A; Lupi A; Cavallino C; Rosso R; Veia A; Bacchini S; Bongo AS;

Ranolazine: effects on ischemic heart. in Recent patents on cardiovascular drug discovery / Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):197-203. doi: 10.2174/15748901113089990023.

2013
AOU Novara

Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS;

New insights in the pathophysiology of acute myocardial infarction detectable by a contemporary troponin assay. in Clinical biochemistry / Clin Biochem. 2013 Aug;46(12):999-1006. doi: 10.1016/j.clinbiochem.2013.03.026. Epub 2013 Apr 9.

2013
AOU Novara

Ferraro S; Biganzoli E; Marano G; Santagostino M; Boracchi P; Panteghini M; Bongo AS;

The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: a cautionary message. in Scandinavian journal of clinical and laboratory investigation / Scand J Clin Lab Invest. 2012 Sep;72(5):355-62. doi: 10.3109/00365513.2012.671491. Epub 2012 Apr 10.

2012
AOU Novara

Ferraro S; Santagostino M; Marano G; Colli E; Vendramin C; Maffé S; Rossi L; Galvani M; Panteghini M; Bongo AS;

Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood. in Clinica chimica acta; international journal of clinical chemistry / Clin Chim Acta. 2012 May 18;413(9-10):888-93. doi: 10.1016/j.cca.2012.01.034. Epub 2012 Feb 7.

2012
AOU Novara

Ferraro S; Ardoino I; Boracchi P; Santagostino M; Ciardi L; Antonini G; Braga F; Biganzoli E; Panteghini M; Bongo AS;

Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2012 May;33(4):308-17. doi: 10.1007/s11239-011-0628-z.

2012
AOU Novara

Lupi A; Secco GG; Rognoni A; Rossi L; Lazzero M; Nardi F; Rolla R; Bellomo G; Bongo AS; Di Mario C;

Different spectrum of vascular complications after angio-seal deployment or manual compression. in The Journal of invasive cardiology / J Invasive Cardiol. 2012 Mar;24(3):90-6.

2012
AOU Novara
ASL Vercelli

Lupi A; Rognoni A; Secco GG; Lazzero M; Plebani L; Cossa G; Reale D; Nardi F; Sansa M; Bongo AS;

Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device. in Perspectives in vascular surgery and endovascular therapy / Perspect Vasc Surg Endovasc Ther. 2012 Mar;24(1):28-36. doi: 10.1177/1531003512442091. Epub 2012 Apr

2012
AOU Novara
ASL Vercelli

Lupi A; Rognoni A; Secco GG; Lazzero M; Plebani L; Cossa G; Reale D; Sansa M; Bongo AS; Di Mario C;

Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target. in Clinical chemistry and laboratory medicine / Clin Chem Lab Med. 2011 Sep;49(9):1397-404. doi: 10.1515/CCLM.2011.607. Epub 2011 May 24.

2011
AOU Novara

Ferraro S; Marano G; Biganzoli EM; Boracchi P; Bongo AS;

Ultra-sensitive troponin I levels to exclude acute myocardial infarction from myocardial injury. in Clinical chemistry and laboratory medicine / Clin Chem Lab Med. 2011 Oct 6;50(1):159-66. doi: 10.1515/CCLM.2011.746.

2011
AOU Novara

Ferraro S; Boracchi P; Santagostino M; Marano G; Vendramin C; Rossi L; Biganzoli EM; Galvani M; Clerico A; Bongo AS;

Update on glycoprotein IIb/IIIa: role in primary coronary intervention. in Cardiovascular & hematological agents in medicinal chemistry / Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):106-12. doi: 10.2174/187152511796196524.

2011
AOU Novara

Rognoni A; Lupi A; Secco GG; Cavallino C; Sansa M; Lazzero M; Bongo AS;

Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. in Circulation journal : official journal of the Japanese Circulation Society / Circ J. 2011;75(2):280-9. doi: 10.1253/circj.cj-10-0186. Epub 2010 Dec 14.

2011
AOU Novara

Lupi A; Navarese EP; Lazzero M; Sansa M; De Servi S; Serra A; Bongo AS; Buffon A;

From multimarker approach to multiplex assays in acute coronary syndromes: what are we searching for? in Acute cardiac care / Acute Card Care. 2010 Mar;12(1):18-24. doi: 10.3109/17482940903578980.

2010
AOU Novara

Ferraro S; Marano G; Bongo AS; Boracchi P; Biganzoli EM;

Different patterns of NT-proBNP secretion in acute coronary syndromes. in Clinica chimica acta; international journal of clinical chemistry / Clin Chim Acta. 2009 Apr;402(1-2):176-81. doi: 10.1016/j.cca.2009.01.005.

2009
AOU Novara

Ferraro S; Lupi A; Marano G; Rossi L; Ciardi L; Vendramin C; Bellomo G; Boracchi P; Bongo AS; Biganzoli E;

Impact of calibration fitting models on the clinical value of chromogranin A. in Clinical chemistry and laboratory medicine / Clin Chem Lab Med. 2009;47(10):1297-303. doi: 10.1515/CCLM.2009.278.

2009
AOU Novara

Ferraro S; Marano G; Ciardi L; Vendramin C; Bongo AS; Bellomo G; Boracchi P; Biganzoli EM;

[The identification of the hibernating myocardium by the study of the changes in the contractile function induced by pharmacological stress]. in Giornale italiano di cardiologia / G Ital Cardiol. 1993 May;23(5):527-31.

1993
AOU Novara

Sacchetti G; Rizzotti M; Rossi L; Sarasso G; Bolognese L; Bongo AS; Dellavesa P; Inglese E; Rossi P;

Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. in Journal of the American College of Cardiology / J Am Coll Cardiol. 1992 Apr;19(5):953-9. doi: 10.1016/0735-1097(92)90277-t.

1992
AOU Novara

Bolognese L; Rossi L; Sarasso G; Prando MD; Bongo AS; Dellavesa P; Rossi P;

Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy. in Circulation / Circulation. 1991 Sep;84(3):1100-6. doi: 10.1161/01.cir.84.3.1100.

1991
AOU Novara

Bolognese L; Sarasso G; Bongo AS; Rossi L; Aralda D; Piccinino C; Rossi P;

[The echo-dipyridamole test early after acute myocardial infarct: echocardiographic aspects and angiographic correlations]. in Giornale italiano di cardiologia / G Ital Cardiol. 1991 Mar;21(3):239-47.

1991
AOU Novara

Sarasso G; Bolognese L; Bongo AS; Aralda D; Rossi L; Piccinino C; Francalacci G; Prando ME; Rossi P;

High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: correlation with exercise testing and coronary angiography. in Journal of the American College of Cardiology / J Am Coll Cardiol. 1989 Aug;14(2):357-63. doi: 10.1016/0735-1097(89)90186-1.

1989
AOU Novara

Bolognese L; Sarasso G; Aralda D; Bongo AS; Rossi L; Rossi P;